Management of papillary and follicular thyroid cancer

Journal of the Royal Society of Medicine

Volumn 95, Issue 7, 2002, Pages 325-326

  Jones, M Keston ^a  

^a SINGLETON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOACTIVE IODINE; THYROGLOBULIN; THYROID HORMONE; THYROTROPIN; THYROXINE;

CANCER ADJUVANT THERAPY; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; HUMAN; LUNG METASTASIS; MORTALITY; PROGNOSIS; SURVIVAL RATE; THORAX RADIOGRAPHY; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 0036069260     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1258/jrsm.95.7.325     Document Type: Editorial

References (11)

1. Long term impact of initial surgical and medical therapy on papillary and follicular cancer
2. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas, a retrospective analysis of 700 patients
3. Variation of survival in adult patients with thyroid cancer in Europe
4. An audit of the management of thyroid cancer in a district general hospital
5. Thyroid cancer management
6. Degree of thyrotrophin suppression as a prognostic determinant in differentiated thyroid cancer
7. Thyroid carcinoma: Papillary and follicular
8. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer
9. Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma